Tiziana Life Sciences Ltd (TLSA)
NASDAQ: TLSA · Real-Time Price · USD
1.390
-0.050 (-3.47%)
At close: Mar 6, 2026, 4:00 PM EST
1.548
+0.158 (11.38%)
After-hours: Mar 6, 2026, 5:30 PM EST
Tiziana Life Sciences Employees
Tiziana Life Sciences had 9 employees as of December 31, 2024. The number of employees did not change compared to the previous year.
Employees
9
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,426,778
Market Cap
177.40M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 9 | 0 | - |
| Dec 31, 2023 | 9 | 0 | - |
| Dec 31, 2022 | 9 | -5 | -35.71% |
| Dec 31, 2021 | 14 | 3 | 27.27% |
| Dec 31, 2020 | 11 | 3 | 37.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ProQR Therapeutics | 166 |
| Molecular Partners AG | 153 |
| Nkarta | 105 |
| Vaxart | 105 |
| Tonix Pharmaceuticals Holding | 81 |
| Compugen | 74 |
| Cartesian Therapeutics | 66 |
| SAB Biotherapeutics | 63 |
TLSA News
- 9 days ago - Tiziana Life Sciences Announces New Biomarker Data Showing Nasal Foralumab Downregulates CSF Inflammation, Upregulates Neuroprotective Pathways, and Correlates with Reduced Microglial Activation on PET Scans in na-SPMS Patients with PIRA - GlobeNewsWire
- 6 weeks ago - Tiziana Life Sciences Announces the Peer-Reviewed Publication of Clinical Study Results for Intranasal Foralumab - GlobeNewsWire
- 7 weeks ago - Tiziana Life Sciences Announces Closing of Oversubscribed $8.8 Million Registered Direct Offering of Ordinary Shares - GlobeNewsWire
- 7 weeks ago - Tiziana Life Sciences Announces Registered Direct Offering of up to approximately $17.6 Million - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences to Present at the 9th Annual Neuroscience Innovation Forum During J.P. Morgan Healthcare Conference Week in San Francisco - GlobeNewsWire
- 2 months ago - Tiziana Files Annual Safety Report for Intranasal Foralumab with FDA - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences Announces Acquisition of Shares by Executive Chairman - GlobeNewsWire
- 2 months ago - Tiziana Life Sciences to Ring the Closing Bell at Nasdaq - GlobeNewsWire